Medical News

RSS

Stent graft can repair abdominal aortic aneurysm

When Dr. Ross Milner repaired Lydia Strebing's life-threatening abdominal aortic aneurysm, she was astonished at how easy it was. "I've had more pain from dental procedures," she said. "This was nothing." Milner, chief of vascular surgery at Loyola University Hospital, repaired the bulging aneurysm by using a catheter to deploy a device called a stent graft.

8 Jun 2011

Low phosphate intake can reduce heart disease

Lowering phosphate intake in humans can reduce heart disease, according to research by experts at the University of Sheffield.

8 Jun 2011

Combined contraceptive pill does not cause weight gain in young women

Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.

8 Jun 2011

FDA approves Mylan's ANDA for Donepezil HCl Tablets to treat dementia linked with Alzheimer's

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Donepezil Hydrochloride (HCl) Tablets, 5 mg and 10 mg, the generic version of Eisai's Aricept Tablets, which are used to treat dementia associated with Alzheimer's disease.

8 Jun 2011

The NY Times: A community hospital closes

A railroad bridge separates Huron Hospital, one of the last remaining institutions in the impoverished neighborhood of East Cleveland, from the city's downtown and its two major hospitals.

8 Jun 2011

$Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS$

Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS

Telik, Inc. today announced the initiation of a Phase 2 clinical trial to evaluate oral Telintra in patients with Revlimid refractory or resistant, deletion 5q myelodysplastic syndrome.

8 Jun 2011

Thermo Fisher Scientific launches new triple quadrupole gas chromatography-mass spectrometry system

Thermo Fisher Scientific Inc. has announced the launch of its new triple quadrupole gas chromatography-mass spectrometry (GC-MS/MS) system designed to offer best-in-class selectivity, analytical performance and productivity. The Thermo Scientific TSQ Quantum XLS Ultra delivers the increased matrix selectivity needed for challenging applications that require lower levels of quantitation in extremely complex matrix extracts. With its exceptional sensitivity, easy detection and reliable peak integration, the system provides superior performance for the most difficult of matrix challenges.

From Thermo Fisher Scientific Inc. 7 Jun 2011

Clinical-research expert moving to Stanford

Steven Goodman, MD, PhD, has worn many hats through his long and varied career, from pediatrician to biostatistician, from epidemiologist to clinical trial expert, from scientist to, well, opera singer. Admittedly, opera has been more of a hobby for him than a career path, but it does give some indication of his ability to master a wide range of subjects.

7 Jun 2011

Linkam tensile stage chosen to control stress in growth of human collagen by the University of Liverpool

Manufacturers temperature controlled microscopy, Linkam Scientific Instruments, have been chosen by the Physics Department of the University of Liverpool to study the effects of controlling stresses applied during the growth of collagen secreted from human fibroblast cells. The research goal of Senior Research Assistant, Dr Caroline Smith, and her colleagues at the University of Liverpool is to advance the treatment of tendon injuries by developing a method of growing oriented human collagen.

From Linkam Scientific Instruments 7 Jun 2011

States wrestle with Medicaid program costs

According to NPR, 15 states are trying to cut back on their Medicaid spending. Meanwhile, a California lawsuit, in which patients and providers are suing the state over changes to the program, is moving forward.

7 Jun 2011

Health law challenges and appeals percolate

The date has been set -- July 13 -- for oral arguments to be heard in a California appeal of a lawsuit against the health overhaul filed by the Pacific Justice Institute. And, in Kansas, the attorney general has signed on to an amicus brief that supports, but does not join, in a lawsuit challenging the measure.

7 Jun 2011

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.

7 Jun 2011

RF Industries second quarter net sales increase 16% to $4,392,000

RF INDUSTRIES, LTD. today announced that for the period ended April 30, 2011, net income increased 23% to $407,000, or $0.06 per diluted share, compared to $330,000, or $0.05 per diluted share, in the second quarter last year. Net sales increased 16% to $4,392,000, compared to $3,778,000 in the same period last year.

7 Jun 2011

Ximedica opens regional office at UEL Center, Minneapolis

Ximedica, a full-service medical device product development firm, announced the opening of its regional office at the University Enterprise Laboratories (UEL) Center in Minneapolis, Minnesota.

7 Jun 2011

Promising results from KAI-4169 program for CKD-MBD presented at ENDO 2011

KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced clinical and preclinical data from its lead program, KAI-4169, at the Endocrine Society's 93rd Annual Meeting (ENDO 2011) taking place in Boston, June 4-7, 2011. KAI-4169 is a novel pharmaceutical agent being developed for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).

7 Jun 2011

First human implant of St. Jude Medical's Portico transcatheter aortic heart valve

St. Jude Medical, Inc., a global medical device company, today announced the first human implant of its Portico transcatheter aortic heart valve. The procedure was performed by Dr. John Webb, director of cardiac catheterization and interventional cardiology at St. Paul's Hospital in Vancouver, British Columbia.

7 Jun 2011

Cyterix raises $9.2M in Series A financing from The Column Group and SV Life Sciences

Cyterix Pharmaceutics, Inc. announced today that the company has raised $9.2 million in a Series A financing from The Column Group and SV Life Sciences. Cyterix is developing novel cancer therapeutics based on a prodrug approach that targets extra-hepatic cytochrome P450 enzymes that are over-expressed in many cancers to a high frequency, but not in normal tissues.

7 Jun 2011

Smoking increases woman's risk for peripheral artery disease 10-fold

A prospective study of initially healthy women aged 45 and over found that smoking is a potent risk factor for symptomatic peripheral artery disease, or PAD. PAD is a serious, often debilitating disorder, caused by narrowing of the arteries in the lower extremities. Symptoms of PAD include pain in the legs with normal activity and a feeling of tiredness in the leg muscles.

7 Jun 2011

FDA accepts Topaz's ivermectin NDA for treatment for head lice infestations

Topaz Pharmaceuticals Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) accepted for filing the New Drug Application (NDA) for the use of ivermectin topical cream as a treatment for head lice infestations in children and adults.

7 Jun 2011

NYC dermatologist announces website launch of BeautyRx Skincare

To introduce BeautyRx Skincare, Neal Schultz, M.D., board-certified New York City dermatologist, proudly announces the website launch of BeautyRx.com. The site will unveil his new line of skincare products forged from insider advances in cosmeceutical technology, and developed over 10 years with ongoing patient feedback from his 10,000 patient visits per year.

7 Jun 2011

Medical News

Stent graft can repair abdominal aortic aneurysm

Low phosphate intake can reduce heart disease

Combined contraceptive pill does not cause weight gain in young women

FDA approves Mylan's ANDA for Donepezil HCl Tablets to treat dementia linked with Alzheimer's

The NY Times: A community hospital closes

Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS

Thermo Fisher Scientific launches new triple quadrupole gas chromatography-mass spectrometry system

Clinical-research expert moving to Stanford

Linkam tensile stage chosen to control stress in growth of human collagen by the University of Liverpool

States wrestle with Medicaid program costs

Health law challenges and appeals percolate

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

RF Industries second quarter net sales increase 16% to $4,392,000

Ximedica opens regional office at UEL Center, Minneapolis

Promising results from KAI-4169 program for CKD-MBD presented at ENDO 2011

First human implant of St. Jude Medical's Portico transcatheter aortic heart valve

Cyterix raises $9.2M in Series A financing from The Column Group and SV Life Sciences

Smoking increases woman's risk for peripheral artery disease 10-fold

FDA accepts Topaz's ivermectin NDA for treatment for head lice infestations

NYC dermatologist announces website launch of BeautyRx Skincare

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News